Th17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis

Copyright © 2024 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 259(2024) vom: 10. Feb., Seite 109898
1. Verfasser: Sonar, Sandip Ashok (VerfasserIn)
Weitere Verfasser: Meitei, Heikrujam Thoihen, Karmakar, Surojit, Mishra, Amrita, Inamdar, Shrirang, Lenka, Nibedita, Lal, Girdhari
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Blood-brain barrier CNS autoimmunity Experimental autoimmune encephalomyelitis Th1 cells Th17 cells Nuclear Receptor Subfamily 1, Group F, Member 3 Myelin-Oligodendrocyte Glycoprotein Transcription Factors Interleukin-23
LEADER 01000caa a22002652 4500
001 NLM36675887X
003 DE-627
005 20240410232359.0
007 cr uuu---uuuuu
008 240114s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2024.109898  |2 doi 
028 5 2 |a pubmed24n1371.xml 
035 |a (DE-627)NLM36675887X 
035 |a (NLM)38185267 
035 |a (PII)S1521-6616(24)00009-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sonar, Sandip Ashok  |e verfasserin  |4 aut 
245 1 0 |a Th17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 29.01.2024 
500 |a Date Revised 10.04.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2024 Elsevier Inc. All rights reserved. 
520 |a Myelin antigen-reactive Th1 and Th17 cells are critical drivers of central nervous system (CNS) autoimmune inflammation. Transcription factors T-bet and RORγt play a crucial role in the differentiation and function of Th1 and Th17 cells, and impart them a pathogenic role in CNS autoimmune inflammation. Mice deficient in these two factors do not develop experimental autoimmune encephalomyelitis (EAE). While T-bet and RORγt are known to regulate the expression of several cell adhesion and migratory molecules in T cells, their role in supporting Th1 and Th17 trafficking to the CNS is not completely understood. More importantly, once Th1 and Th17 cells reach the CNS, how the function of these transcription factors modulates the local inflammatory response during EAE is unclear. In the present study, we showed that myelin oligodendrocyte glycoprotein 35-55 peptide (MOG35-55)-specific Th1 cells deficient in RORγt could cross the blood-brain barrier (BBB) but failed to induce demyelination, apoptosis of neurons, and EAE. Pathogenic Th17 cell-derived cytokines GM-CSF, TNF-α, IL-17A, and IL-21 significantly increased the surface expression of IL-23R on neuronal cells. Furthermore, we showed that, in EAE, neurons in the brain and spinal cord express IL-23R. IL-23-IL-23R signaling in neuronal cells caused phosphorylation of STAT3 (Ser727 and Tyr705) and induced cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase-1 (PARP-1) molecules in an IL-23R-dependent manner and caused apoptosis. Thus, we provided a mechanism showing that T-bet is required to recruit pathogenic Th17 cells to the CNS and RORγt-mediated inflammatory response to drive the apoptosis of IL-23R+ neurons in the CNS and cause EAE. Understanding detailed molecular mechanisms will help to design better strategies to control neuroinflammation and autoimmunity. ONE SENTENCE SUMMARY: IL-23-IL-23R signaling promotes apoptosis of CNS neurons 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Blood-brain barrier 
650 4 |a CNS autoimmunity 
650 4 |a Experimental autoimmune encephalomyelitis 
650 4 |a Th1 cells 
650 4 |a Th17 cells 
650 7 |a Nuclear Receptor Subfamily 1, Group F, Member 3  |2 NLM 
650 7 |a Myelin-Oligodendrocyte Glycoprotein  |2 NLM 
650 7 |a Transcription Factors  |2 NLM 
650 7 |a Interleukin-23  |2 NLM 
700 1 |a Meitei, Heikrujam Thoihen  |e verfasserin  |4 aut 
700 1 |a Karmakar, Surojit  |e verfasserin  |4 aut 
700 1 |a Mishra, Amrita  |e verfasserin  |4 aut 
700 1 |a Inamdar, Shrirang  |e verfasserin  |4 aut 
700 1 |a Lenka, Nibedita  |e verfasserin  |4 aut 
700 1 |a Lal, Girdhari  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 259(2024) vom: 10. Feb., Seite 109898  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:259  |g year:2024  |g day:10  |g month:02  |g pages:109898 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2024.109898  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 259  |j 2024  |b 10  |c 02  |h 109898